IDBYDNA
We passionately believe that infectious disease patients should be treated with the same precision that cancer patients receive today. As our population increases, our economies become more global, and we continue over-usage of broad-spectrum antibiotics, infectious diseases are going to continue to spread and become more pernicious. Our clinical practices must evolve with disease to become more precise in our diagnostic and treatment tools. At IDbyDNA, our goal is to accelerate these solutions and uncover the microbial world to reduce infectious disease-associated morbidity and mortality
IDBYDNA
Industry:
Biotechnology Health Care Health Diagnostics Life Science
Founded:
2014-11-01
Address:
Salt Lake City, Utah, United States
Country:
United States
Website Url:
http://www.idbydna.com
Total Employee:
11+
Status:
Active
Total Funding:
64 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Current Advisors List
Current Employees Featured
Founder
Investors List
Horizon Technology Finance
Horizon Technology Finance investment in Debt Financing - IDbyDNA
Sand Hill Angels
Sand Hill Angels investment in Convertible Note - IDbyDNA
Artis Ventures (AV)
Artis Ventures (AV) investment in Series B - IDbyDNA
Genesys Capital
Genesys Capital investment in Series B - IDbyDNA
Sand Hill Angels
Sand Hill Angels investment in Series B - IDbyDNA
ARUP Laboratories
ARUP Laboratories investment in Series A - IDbyDNA
Abstract Ventures
Abstract Ventures investment in Series A - IDbyDNA
Artis Ventures (AV)
Artis Ventures (AV) investment in Series A - IDbyDNA
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-24 | IDbyDNA Appoints Susan E. Daniels, Ph.D., as Vice President of R&D and Member of Executive Committee |
